The prevention and management of distant metastases in women with breast cancer

Stefan Glück

Research output: Contribution to journalReview article

12 Scopus citations

Abstract

About one-third of all women diagnosed with breast cancer face the risk of recurrence, which can occur at any stage of disease, observation time, and after any treatment modality. Most recurrence comes in the form of distant metastasis, which is the major cause of death in women with breast cancer. Treatments shown to decrease the risk of breast cancer recurrence, especially distant metastasis, will likely produce a survival benefit and a potentially significant improvement in quality of life in women with early breast cancer. New third-generation aromatase inhibitors (anastrozole, exemestane, and letrozole) that have been shown to be well tolerated have the potential to contribute to benefits beyond those seen with tamoxifen.

Original languageEnglish (US)
Pages (from-to)6-13
Number of pages8
JournalCancer Investigation
Volume25
Issue number1
DOIs
StatePublished - Jan 1 2007

Keywords

  • Aromatase inhibitors
  • Breast cancer
  • Distant metastases
  • Recurrence
  • Tamoxifen

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'The prevention and management of distant metastases in women with breast cancer'. Together they form a unique fingerprint.

  • Cite this